Susquehanna International Group’s iHuman IH Stock Holding History

Susquehanna International Group’s Portfolio IH Stock Details IH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$17.4K	Sell	10,212 -92	-0.9%	-$171	﹤0.01%	12877
2025 Q4	$21.6K	Buy	+10,304	New	+$27.3K	﹤0.01%	11938
2024 Q2	–	Sell	-11,162	Closed	-$19K	–	12585
2024 Q1	$19K	Buy	+11,162	New	+$25.9K	﹤0.01%	11828

Other funds holding IH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group's IH Position: Q1 2026 in Review

Susquehanna International Group reduced its iHuman (IH) stake by 0.89% in Q1 2026, selling an estimated $171 and leaving 10,212 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #12877.

Susquehanna International Group first reported a position in IH in Q1 2024 and has held it in 3 quarters since. The position peaked at $21.6K in Q4 2025. 7 funds tracked by Wall St. Rank hold IH as of Q1 2026.

Susquehanna International Group held 10,212 shares of iHuman worth $17.4K as of Q1 2026.
Susquehanna International Group sold 92 iHuman shares in Q1 2026, an estimated $171.
iHuman made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12877 holding.
Susquehanna International Group first reported a position in iHuman in Q1 2024 and has held it in 3 quarters since.
Susquehanna International Group's iHuman position peaked at $21.6K in Q4 2025.
7 funds tracked by Wall St. Rank held iHuman as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.